학술논문
CO86 Improving External Validity of Trial Outcomes When Estimating Subgroup QALY Gains: A Case Study of Pembrolizumab±Chemotherapy Vs. Cetuximab+Platinum-Based Chemotherapy (‘EXTREME’) in Squamous Cell Carcinoma of the Head and Neck
Document Type
Abstract
Author
Source
In Value in Health June 2023 26(6) Supplement:S30-S30
Subject
Language
ISSN
1098-3015